Article ; Online: Safety and performance of a hybrid closed-loop insulin delivery system with carbohydrate suggestion in adults with type 1 diabetes prone to hypoglycemia.
Diabetes research and clinical practice
2023 Volume 205, Page(s) 110956
Abstract: Aims: To evaluate the safety and performance of a hybrid closed-loop (HCL) system with automatic carbohydrate suggestion in adults with type 1 diabetes (T1D) prone to hypoglycemia.: Methods: A 32-hour in-hospital pilot study, including a night period, ...
Abstract | Aims: To evaluate the safety and performance of a hybrid closed-loop (HCL) system with automatic carbohydrate suggestion in adults with type 1 diabetes (T1D) prone to hypoglycemia. Methods: A 32-hour in-hospital pilot study, including a night period, 4 meals and 2 vigorous unannounced 45-minute aerobic sessions, was conducted in 11 adults with T1D prone to hypoglycemia. The primary outcome was the percentage of time in range 70-180 mg/dL (TIR). Main secondary outcomes were time below range < 70 mg/dL (TBR < 70) and < 54 (TBR < 54). Data are presented as median (10th-90th percentile ranges). Results: The participants, 6 (54.5%) men, were 24 (22-48) years old, and had 22 (9-32) years of T1D duration. All of them regularly used an insulin pump and a continuous glucose monitoring system. The median TIR was 78.7% (75.6-91.2): 92.7% (68.2-100.0) during exercise and recovery period, 79.3% (34.9-100.0) during postprandial period, and 95.4% (66.4-100.0) during overnight period. The TBR < 70 and TBR < 54 were 0.0% (0.0-6.6) and 0.0% (0.0-1.2), respectively. A total of 4 (3-9) 15-g carbohydrate suggestions were administered per person. No severe acute complications occurred during the study. Conclusions: The HCL system with automatic carbohydrate suggestion performed well and was safe in this population during challenging conditions in a hospital setting. |
---|---|
MeSH term(s) | Male ; Adult ; Humans ; Young Adult ; Middle Aged ; Female ; Insulin/adverse effects ; Diabetes Mellitus, Type 1/drug therapy ; Blood Glucose ; Hypoglycemic Agents/adverse effects ; Blood Glucose Self-Monitoring ; Pilot Projects ; Treatment Outcome ; Insulin Infusion Systems ; Hypoglycemia/epidemiology ; Insulin, Regular, Human/therapeutic use |
Chemical Substances | Insulin ; Blood Glucose ; Hypoglycemic Agents ; Insulin, Regular, Human |
Language | English |
Publishing date | 2023-10-14 |
Publishing country | Ireland |
Document type | Journal Article |
ZDB-ID | 632523-3 |
ISSN | 1872-8227 ; 0168-8227 |
ISSN (online) | 1872-8227 |
ISSN | 0168-8227 |
DOI | 10.1016/j.diabres.2023.110956 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 2047: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.